CD8 Cytospheres Kit

FDA 510(k) K923951 · Coulter Electronics, Inc.

Substantially Equivalent

510(k) numberK923951

Submission

Device name
CD8 Cytospheres Kit
Applicant
Coulter Electronics, Inc.
Hialeah, FL, US
Received
August 6, 1992
Decision date
April 25, 1994
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
MAM – Dna-Probe, B And T Lymphocyte
Device class
Class II (moderate risk)
Regulation
21 CFR 864.5220
Specialty
Hematology

More from Coulter Electronics, Inc.

510(k)DeviceDecision
K930119Coulter Retic-C Cell ControlJPK · Traditional 04/05/1993SE
K921279CD4 Cytospheres KitGKZ · Traditional 12/29/1992SE
K923530Coulter Multi-Q-PrepGKH · Traditional 10/14/1992SE
K922181Coulter MH009GKZ · Traditional 08/17/1992SE
K922704Coulter Maxm W/ AutoloaderGKZ · Traditional 07/27/1992SE
K921567Coulter MH017GKZ · Traditional 07/06/1992SE
K912133PX Coulter(R) Cell ControlJPK · Traditional 07/17/1991SE
K911385Coulter(R) MH010GKZ · Traditional 06/17/1991SE
K905771Coulter Dart Ast (Got) ReagentCIT · Traditional 02/26/1991SE
K905767Coulter Dart Alt (GPT) ReagentCKA · Traditional 01/25/1991SE

Questions and answers

When was CD8 Cytospheres Kit cleared by the FDA?

CD8 Cytospheres Kit (K923951) received a 510(k) decision of Substantially Equivalent on April 25, 1994, 627 days after the submission was received.

What is the product code of K923951?

The FDA product code is MAM – Dna-Probe, B And T Lymphocyte, a Class II (moderate risk) device regulated under 21 CFR 864.5220.